rs2230199
|
|
Age related macular degeneration
|
G |
0.900 |
GeneticVariation
|
GWASCAT |
Genome-wide analysis of disease progression in age-related macular degeneration.
|
29346644 |
2018 |
rs2230199
|
|
Age related macular degeneration
|
|
0.900 |
GeneticVariation
|
GWASCAT |
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.
|
26691988 |
2016 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASCAT |
Seven new loci associated with age-related macular degeneration.
|
23455636 |
2013 |
rs2230199
|
|
Age related macular degeneration
|
|
0.900 |
GeneticVariation
|
GWASDB |
Seven new loci associated with age-related macular degeneration.
|
23455636 |
2013 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASDB |
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes.
|
22705344 |
2012 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASCAT |
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.
|
21665990 |
2011 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASDB |
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration.
|
21665990 |
2011 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASCAT |
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
|
20385819 |
2010 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASCAT |
Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration.
|
20861866 |
2010 |
rs2230199
|
|
Age related macular degeneration
|
|
0.900 |
GeneticVariation
|
GWASDB |
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).
|
20385826 |
2010 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASDB |
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration.
|
20385819 |
2010 |
rs2230199
|
|
Age related macular degeneration
|
C |
0.900 |
GeneticVariation
|
GWASDB |
Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration.
|
20861866 |
2010 |
rs2230199
|
|
Age related macular degeneration
|
|
0.900 |
GeneticVariation
|
GWASCAT |
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC).
|
20385826 |
2010 |
rs121909583
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
|
20513133 |
2010 |
rs121909583
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
|
19821824 |
2010 |
rs121909583
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Atypical hemolytic-uremic syndrome.
|
19846853 |
2009 |
rs121909583
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
|
18796626 |
2008 |
rs121909583
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
T |
0.800 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs121909584
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
|
20513133 |
2010 |
rs121909584
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
|
19821824 |
2010 |
rs121909584
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Atypical hemolytic-uremic syndrome.
|
19846853 |
2009 |
rs121909584
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
|
18796626 |
2008 |
rs121909584
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
A |
0.800 |
SusceptibilityMutation
|
CLINVAR |
|
|
|
rs121909585
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome.
|
20513133 |
2010 |
rs121909585
|
|
HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5
|
|
0.800 |
GeneticVariation
|
UNIPROT |
Clinical practice guidelines for the management of atypical haemolytic uraemic syndrome in the United Kingdom.
|
19821824 |
2010 |